Renaissance Technologies’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-286,395
Closed -$46.1K 3968
2024
Q4
$46.1K Buy
286,395
+40,996
+17% +$6.6K ﹤0.01% 3401
2024
Q3
$56.8K Buy
245,399
+27,700
+13% +$6.41K ﹤0.01% 3331
2024
Q2
$118K Buy
217,699
+15,200
+8% +$8.26K ﹤0.01% 3154
2024
Q1
$207K Buy
202,499
+23,600
+13% +$24.1K ﹤0.01% 3219
2023
Q4
$102K Buy
178,899
+30,700
+21% +$17.5K ﹤0.01% 3297
2023
Q3
$154K Buy
148,199
+13,400
+10% +$13.9K ﹤0.01% 3153
2023
Q2
$190K Buy
134,799
+9,500
+8% +$13.4K ﹤0.01% 3317
2023
Q1
$199K Sell
125,299
-14,488
-10% -$23K ﹤0.01% 3289
2022
Q4
$204K Buy
139,787
+43,888
+46% +$64K ﹤0.01% 3412
2022
Q3
$409K Buy
95,899
+2,500
+3% +$10.7K ﹤0.01% 3046
2022
Q2
$362K Buy
93,399
+45,399
+95% +$176K ﹤0.01% 3346
2022
Q1
$228K Sell
48,000
-67,700
-59% -$322K ﹤0.01% 3597
2021
Q4
$422K Buy
+115,700
New +$422K ﹤0.01% 3162
2019
Q4
Sell
-2,387
Closed -$60K 3795
2019
Q3
$60K Sell
2,387
-4,971
-68% -$125K ﹤0.01% 3315
2019
Q2
$187K Buy
7,358
+5,597
+318% +$142K ﹤0.01% 3314
2019
Q1
$75K Buy
+1,761
New +$75K ﹤0.01% 3332
2017
Q4
Sell
-2,128
Closed -$144K 3530
2017
Q3
$144K Sell
2,128
-463
-18% -$31.3K ﹤0.01% 3056
2017
Q2
$245K Sell
2,591
-604
-19% -$57.1K ﹤0.01% 2952
2017
Q1
$458K Buy
3,195
+36
+1% +$5.16K ﹤0.01% 2792
2016
Q4
$400K Buy
3,159
+457
+17% +$57.9K ﹤0.01% 2837
2016
Q3
$413K Buy
2,702
+1,405
+108% +$215K ﹤0.01% 2861
2016
Q2
$149K Buy
1,297
+963
+288% +$111K ﹤0.01% 3105
2016
Q1
$38K Buy
+334
New +$38K ﹤0.01% 3299
2014
Q3
Sell
-109
Closed -$149K 2987
2014
Q2
$149K Sell
109
-2
-2% -$2.73K ﹤0.01% 2613
2014
Q1
$153K Buy
+111
New +$153K ﹤0.01% 2658